Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy

NCT01935622 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped End of funding

Conditions

Non-ischemic Cardiomyopathy
Systolic Heart Failure (NYHA II-III)

Interventions

DRUG: Doxycycline
DRUG: placebo

Sponsor

Virginia Commonwealth University